Sonova Holding AG (SONVF) Stock Price & Analysis
Sonova Holding AG (SONVF) — price $336.09 (0.00%), as of the Nov 20, 2026 trading session; market cap $20.0B. Expected results May 18, 2027.
Educational signal · not a buy or sell recommendation · How to read this
Sonova Holding AG · SONVF · Healthcare · Medical - Devices
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Price as of Nov 20, 2026
Key Statistics
No MoonshotScore yet: we have not published a score for this company.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $336.09 | |
| Change on the day | 0.00% | |
| 52-week range | $208.55–$356.00 | |
| Market capitalisation | $20.0B | — |
| Price / earnings (trailing) | 34.69 | |
| Shares traded on the day | 179 | |
| Beta (volatility vs the S&P 500) | 1.11 | |
| Dividends per share (last 12 months) | $5.81 | |
| Dividend yield (last 12 months) | 1.71% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
We also believe there is some degree of sell-in effect from a busy launch period in the second quarter.
Elodie Carr-Cingari · Statement from
Based on currently available tracked market data and our estimates, we believe that the global hearing aid market grew around 5% during first half with an acceleration in the second quarter, supported by a big launch season.
Elodie Carr-Cingari · Statement from
How to read these dates
A statement's date is the earnings call where it was made, not a deadline. Management expectations and estimated dates can change.
Other perspectives
Council score for Sonova Holding AG (SONVF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Sonova Holding AG (SONVF), and what does it report?
Short answer
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Healthcare / Medical Devices Headquarters: Laubisrutistrasse 28, Stäfa, ZH, 8712, CH. It employs 18,447 people and is led by Eric Alain Bernard. In Q2 FY2027 it reported revenue of CHF 1.76B and net income of CHF 242M. The market values it at $20.0B.
What do the latest results show for Sonova Holding AG (SONVF)?
Short answer · as of
The most recent reported quarter, Q2 FY2027, carried revenue of CHF 1.76B. Against analyst estimates the company has EPS beat 4 of the last 8 reports.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $2.19B Nov 12, 2026
- Latest report · revenue estimate
- $2.18B Nov 12, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 12, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 12, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 12, 2026 | $2.19B | $2.18B | $6.2000 | $5.3100 |
| May 18, 2026 | $2.22B | Not available | $5.0300 | Not available |
| Nov 14, 2025 | $2.28B | $2.26B | $3.9700 | $5.5000 |
| May 9, 2025 | $2.36B | $2.46B | $7.0900 | $7.1400 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2027 | CHF 1.76B | CHF 242M | CHF 4.06 (diluted) |
| Q4 FY2026 | CHF 1.78B | CHF 349M | CHF 4.03 (diluted) |
| Q2 FY2026 | CHF 1.81B | CHF 188M | CHF 3.16 (diluted) |
| Q4 FY2025 | CHF 2.03B | CHF 332M | CHF 5.55 (diluted) |
What are the financial strengths and risks for Sonova Holding AG (SONVF)?
Short answer · as of
The distress and quality screens read Altman Z 5.37 · Piotroski F 8. Trailing ratios: ROE 18.3% · ROA 8.3% · current ratio 1.69 · earnings yield 2.8% · free-cash-flow yield 4.0%.
What should you watch next at Sonova Holding AG (SONVF)?
Short answer · as of
The next earnings report is expected on May 18, 2027.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
And as I mentioned, we expect those investments to be in a low double-digit Swiss franc amount in the second half.
Elodie Carr-Cingari ·
So this is also reflected in our guidance for the full year.
Eric Bernard ·
What the records here don't tell us
- Detailed statement figures are not shown because their conversion to USD has not been verified.
- No insider Form 4 transaction falls inside the window this page reads.
- Fewer than two score snapshots exist, so no score trend is shown.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held SONVF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported SONVF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About SONVF (Healthcare)
These answers are editorial: 1 of these 8 answers is drawn from the SONVF research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is SONVF a good stock to buy?
Stock Expert AI does not rate SONVF buy, sell or hold. Sonova Holding AG has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the SONVF stock price today?
The last price recorded for Sonova Holding AG (SONVF), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Sonova Holding AG do?
Sonova Holding AG is a global leader in the hearing care industry, focused on designing, developing, manufacturing, and distributing hearing solutions. The company operates through two segments: Hearing Instruments and Cochlear Implants.
What are the key factors to evaluate for SONVF?
Evaluate SONVF on fundamentals, analyst consensus, and risk factors. To weigh it, start with the trailing P/E under Price & valuation on this page. Geographic Expansion: Sonova can expand its presence in emerging markets such as China, India, and Brazil. Not financial advice.
How frequently does SONVF data refresh on this page?
SONVF's price is the last quote we recorded, from the Nov 20, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven SONVF's recent stock price performance?
Sonova Holding AG (SONVF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand portfolio (Phonak, Unitron, Hansaton). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SONVF overvalued or undervalued right now?
The trailing P/E of Sonova Holding AG (SONVF) is listed under Price & valuation on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research SONVF before investing?
Before investing in Sonova Holding AG (SONVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 40 figures on this page — 1 from SEC filings and earnings calls, 30 from Financial Modeling Prep (FMP), 4 with no recorded source, 4 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com